Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71 crores with
(AUROPHARMA)
XNSE:AUROPHARMA, XBOMAUROPHARMA
Aurobindo Pharma Ltd (AUROPHARMA) Q3 FY21 Earnings Concall Transcript
Aurobindo Pharma Ltd (NSE:AUROPHARMA) Q3 FY21 earnings concall dated Feb. 10, 2021. Corporate Participants: Krishna Kiran -- Manager of Investor Relations Santhanam